EUVIMEDEUVIMED entdecken
Crossref

Free Nucleic Acids in the ChAdOx1 nCov-19-S Adenovirus Vector Vaccine Contribute to an Anti-platelet Factor 4 Antibody Response

Florian Siegerist, Alexander Reder, Raghavendra Palankar, Jan Wesche, Luisa Müller, Stephan Michalik, Jens van den Brandt, Jens Hoppen, Linda Schönborn iD, Thomas Thiele, Uwe Völker, Nicole Endlich und 1 weitere

Thrombosis and Haemostasis · 2026-11 · 126 (11) · 1126-1132

DOI: 10.1055/a-2736-5418 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Thrombosis and Haemostasis, online erschienen am 13.11.2025. Verfasst von Florian Siegerist und 12 weiteren Autor:innen. Beteiligte Einrichtung: Institute for Anatomy and Cell Biology, Universitätsmedizin Greifswald, Greifswald, Germany. Hauptthemen laut MEDLINE: Platelet Factor 4, COVID-19 Vaccines, COVID-19, SARS-CoV-2. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 20 Literaturangaben. Gefördert von: Deutsche Forschungsgemeinschaft, DFG, German Research Foundation, EMA service.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Vaccination against SARS-CoV-2 was instrumental in controlling the COVID-19 pandemic. Rare cases of vaccine-induced immune thrombocytopenia and thrombosis (VITT) emerged following vaccination with the adenovirus vector-based vaccines ChAdOx1 nCov-19-S and Ad26.COV2.S. VITT is mediated by high-titer IgG anti-platelet factor 4 (PF4) antibodies that activate platelets, leading to thrombosis and thrombocytopenia. Similar antibodies have been detected following natural adenovirus infections, suggesting a common immunological trigger. This indicates that a constituent of adenovirus is relevant. Adenovirus is a DNA virus. Virion-unbound viral DNA is present in natural adenovirus infections. To identify whether free virion-unbound DNA is present in ChAdOx1-nCoV19 vaccine and whether adenoviral DNA enhances the immune response to PF4 in mice. We assessed ChAdOx1 nCov-19-S for virion-unbound DNA and differentiated free human and free adenovirus DNA by sequencing. We immunized mice with ChAdOx1 nCov-19-S and its fractions, in which we removed proteins by proteinase K and/or DNA by DENERASE. Using ultracentrifugation and proteinase K digestion, we isolated and characterized free nucleic acids, confirming the presence of both adenoviral and host cell-derived DNA in ChAdOx1 nCov-19-S. Mice immunized with PF4 in combination with ChAdOx1 nCov-19-S or its virion-free supernatant—but not with PF4 alone—developed a strong anti-PF4 IgG response, an effect completely abolished by nuclease (DENARASE) treatment. Virion-unbound DNA in ChAdOx1 nCov-19-S contributes to anti-PF4 antibody formation. This highlights the potential of reducing virion-unbound DNA in vaccine formulations to mitigate unintended immune responses to PF4.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Platelet Factor 4COVID-19 VaccinesCOVID-19SARS-CoV-2DNA, ViralAdenoviridaeAnimalsChAdOx1 nCoV-19HumansMiceFemaleImmunoglobulin GAntibody FormationGenetic Vectors

Substanzen

Platelet Factor 4ChAdOx1 nCoV-19COVID-19 VaccinesDNA, ViralImmunoglobulin GPF4 protein, human

Autor:innen und Institutionen

  • Institute for Anatomy and Cell Biology, Universitätsmedizin Greifswald, Greifswald, Germany.
  • Neonatology and Pediatric Intensive Care Medicine, Universitätsmedizin Greifswald, Greifswald, Greifswald, Germany.
  • German Center for Child and Adolescent Health (DZKJ), partner site Greifswald/Rostock, Germany.
  • Interfaculty Institute for Genetics and Functional Genomics, Department Functional Genomics, Universitätsmedizin Greifswald, Greifswald, Germany.
  • Institute of Transfusion Medicine, Universitätsmedizin Greifswald, Greifswald, Germany.
  • Central Core and Research Facility of Laboratory Animals (ZSFV), University Medicine Greifswald, Greifswald, Germany.

ORCID-Profile: Linda Schönborn, Andreas Greinacher

Förderung

  • Deutsche Forschungsgemeinschaft
  • DFG, German Research Foundation
  • EMA service
  • Forschungsverbund Molekulare Medizin
  • Universitätsmedizin Greifswald
  • American Society of Hematology

Zitieren

APA

Siegerist, F., Reder, A., Palankar, R., Wesche, J., Müller, L., Michalik, S., Brandt, J. V. D., Hoppen, J., Schönborn, L., Thiele, T., Völker, U., Endlich, N., & Greinacher, A. (2026). Free Nucleic Acids in the ChAdOx1 nCov-19-S Adenovirus Vector Vaccine Contribute to an Anti-platelet Factor 4 Antibody Response. Thrombosis and Haemostasis, 126(11), 1126-1132. https://doi.org/10.1055/a-2736-5418

Vancouver

Siegerist F, Reder A, Palankar R, Wesche J, Müller L, Michalik S, et al. Free Nucleic Acids in the ChAdOx1 nCov-19-S Adenovirus Vector Vaccine Contribute to an Anti-platelet Factor 4 Antibody Response. Thrombosis and Haemostasis. 2026;126(11):1126-1132. doi:10.1055/a-2736-5418

BibTeX
@article{Siegerist2026,
  author = {Siegerist, Florian and Reder, Alexander and Palankar, Raghavendra and Wesche, Jan and Müller, Luisa and Michalik, Stephan and Brandt, Jens van den and Hoppen, Jens and Schönborn, Linda and Thiele, Thomas and Völker, Uwe and Endlich, Nicole and Greinacher, Andreas},
  title = {Free Nucleic Acids in the ChAdOx1 nCov-19-S Adenovirus Vector Vaccine Contribute to an Anti-platelet Factor 4 Antibody Response},
  journal = {Thrombosis and Haemostasis},
  year = {2026},
  volume = {126},
  number = {11},
  pages = {1126--1132},
  doi = {10.1055/a-2736-5418}
}
Kostenlos starten →